Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

HIV Prevalence and Undiagnosed Infection among a Community Sample of Gay and Bisexual Men in Scotland, 2005–2011: Implications for HIV Testing Policy and Prevention

HIV Prevalence and Undiagnosed Infection among a Community Sample of Gay and Bisexual Men in Scotland, 2005–2011: Implications for HIV Testing Policy and Prevention

  • Lesley A. Wallace, 
  • Jessica Li, 
  • Lisa M. McDaid
PLOS
x

Abstract

Objective

To examine HIV prevalence, HIV testing behaviour, undiagnosed infection and risk factors for HIV positivity among a community sample of gay men in Scotland.

Methods

Cross-sectional survey of gay and bisexual men attending commercial gay venues in Glasgow and Edinburgh, Scotland with voluntary anonymous HIV testing of oral fluid samples in 2011. A response rate of 65.2% was achieved (1515 participants).

Results

HIV prevalence (4.8%, 95% confidence interval, CI 3.8% to 6.2%) remained stable compared to previous survey years (2005 and 2008) and the proportion of undiagnosed infection among HIV-positive men (25.4%) remained similar to that recorded in 2008. Half of the participants who provided an oral fluid sample stated that they had had an HIV test in the previous 12 months; this proportion is significantly higher when compared to previous study years (50.7% versus 33.8% in 2005, p<0.001). Older age (>25 years) was associated with HIV positivity (1.8% in those <25 versus 6.4% in older ages group) as was a sexually transmitted infection (STI) diagnosis within the previous 12 months (adjusted odds ratio 2.13, 95% CI 1.09–4.14). There was no significant association between age and having an STI or age and any of the sexual behaviours recorded.

Conclusion

HIV transmission continues to occur among gay and bisexual men in Scotland. Despite evidence of recent testing within the previous six months, suggesting a willingness to test, the current opt-out policy may have reached its limit with regards to maximising HIV test uptake. Novel strategies are required to improve regular testing opportunities and more frequent testing as there are implications for the use of other biomedical HIV interventions.

Introduction

Transmission of HIV continues to occur among men who have sex with men (MSM) in Scotland and the rest of the UK. There have been annual increases in the number of reported diagnoses in the past ten years; these reports represent a combination of both recently acquired and longstanding HIV infection [1]. This is partly due to increased testing uptake, most probably as a result of the change to opt-out HIV testing when an HIV test is offered in the context of routine, recommended sexual health testing to those attending specialist services, for example, genitourinary medicine (GUM) clinics – a policy implemented as part of the Scottish Government's Sexual Health Strategy and Action Plan in the early part of the last decade to normalise HIV testing [2]. Between 2003, when opt-out testing began, and 2008 an 83% increase (to 3868 tests) was observed [3]. There was no change in the HIV prevalence [3], [4]. Thus, increased test uptake does not fully explain the sustained epidemic in this group, and there is evidence of new transmissions occurring [1][5].

The continuing transmission of HIV is a public health concern. A study in Scotland among those undergoing repeat HIV testing estimated HIV incidence among MSM (15 per 1000 person years) was three to four fold higher than other populations at risk of, and tested for, HIV: this has remained unchanged since the late 1980s [6]. Recent data suggest that one in five HIV infected MSM remain undiagnosed and it is estimated that this population accounts for around half of all new HIV transmissions [1], [7], [8]. In 2008, we reported that the sustained increase in HIV testing among MSM in Scotland was accompanied by a (non-significant) decrease in undiagnosed infection (from 40% to 25% of those testing HIV-positive) [9]. In this paper we examine HIV prevalence, HIV testing and the risk factors associated with HIV positivity among a community sample of gay and bisexual men in Scotland in 2011 and explore whether there has been further change since 2008.

Methods

Using a form of time and location sampling [9], the MRC Gay Men's Sexual Health Survey collected anonymous, self-complete questionnaires and (Orasure) oral fluid specimens from representative samples of MSM in 17 gay commercial venues (15 bars and two saunas) in Glasgow and Edinburgh in May 2011. A team of temporary fieldworkers distributed and collected questionnaires in bars at two different time points in the early (19:00–21:00), and late evening (21:00–23:00) over the two week survey period. No bar was visited twice in the same evening and at the end of the survey period each bar had been visited at both time points on each day of the week. Each sauna was visited six times during the survey; for a two hour period (17:00–19:00) on Thursdays and between 14:00–17:00 on Saturdays and Sundays. Fieldworkers were trained to ask men if they had already completed the survey to ensure no duplicate reporting. When approached more than once in the venues men were asked to acknowledge that they had already completed the questionnaire and this was recorded on the response rate forms. Ethical approval was granted by University of Glasgow College of Social Sciences Ethics Committee. Copies of the questionnaires are available on the study website http://gaymensurvey.sphsu.mrc.ac.uk/data-sharing.

Questionnaires included questions related to demographics, HIV testing, self-reported HIV status, STI experience, and sexual risk behaviours (number of sexual partners, anal sex partners, and unprotected anal intercourse [UAI] partners in the previous 12 months). Oral fluid specimens were analysed at the West of Scotland Specialist Virology Centre. These were tested for anti-HIV using the Vironostika HIV Uni-Form II Ag/Ab enzyme immunoassay. Positive samples were re-tested and, if repeatedly reactive, were confirmed using western blot. Chi-square and Fisher's Exact tests were used for bivariate comparisons and multivariate logistic regression models, adjusting for age, qualification level, employment status and frequency of gay scene use, which differed between the surveys, were used to estimate odds ratios (ORs) and 95% confidence intervals.

1515 men participated in the survey (65.2% response rate (RR)): 848 in Glasgow (66.4% RR) and 667 in Edinburgh (63.7% RR). 1218 men provided oral fluid specimens (80.4% of men surveyed; 52.4% RR): 687 in Glasgow (81.0% of men surveyed; 53.8% RR) and 531 in Edinburgh (79.7% of men surveyed; 50.6% RR). One man from Edinburgh provided an oral fluid specimen but did not complete a questionnaire and was therefore excluded from the analyses.

Results

Sample characteristics

The 297 men (19.6%) who completed questionnaires but did not provide oral fluid specimens were compared with the 1217 who provided specimens. Men who provided specimens were more likely to be younger, report UAI with 2+ partners, UAI with casual partners, and UAI with partners of unknown or discordant HIV status. When controlling for the significant factors in multivariate analysis, men aged 36–45 compared to those aged 16–25 were less likely to have provided a specimen (adjusted odds ratio, AOR 0.68, 95% confidence interval, CI, 0.48 to 0.97) and men with casual UAI partners (AOR 1.60, 95% CI 1.02 to 2.52) were more likely to have provided an oral fluid specimen. There were no differences in HIV testing or self-reported HIV status between the two groups.

HIV Prevalence

Of the 1217 men who provided an oral fluid specimen, 59 were HIV-positive (4.8%, 95% CI: 3.8% to 6.2%) (Table 1). HIV prevalence was 4.4% in Glasgow (95% CI: 3.1% to 6.2%) and 5.5% in Edinburgh (95% CI: 3.8% to 7.7%). The factors associated with having a positive test result are shown in Table 1. At the bivariate level, age and having an STI in the previous 12 months were significantly associated with a positive test result (Table 1). Prevalence was significantly higher among men older than 25 (with a mean age of 37 for positive men and 32 for negative men) and was lowest among men who had never been tested (0.5%). After adjusting for age (data not shown), having a positive test result was also significantly higher among men who reported UAI with two or more partners in the previous 12 months (AOR 1.98, 95% CI 1.03 to 3.80) and having a sexually transmitted infection (STI) in the previous 12 months (AOR 2.57, 95% CI 1.37 to 4.80). When all sexual behaviours were controlled for, in addition to age, in the multivariate model (data not shown), the odds remained significantly higher for men aged 26–35 (AOR 2.74, 95% CI 1.11 to 6.78), 36–45 (AOR 6.51 95% CI 2.72 to 15.60), and 46+ (AOR 2.98, 95% CI 1.04 to 8.52) compared to men aged 16–25, and those who had experienced an STI in the previous 12 months (AOR 2.13, 95% CI 1.09 to 4.14). There were no significant interactions found between age and STI experience or age and any of the sexual behaviours.

thumbnail
Table 1. HIV status by demographic characteristics and behavioural risk factors of MSM who answered the questionnaire and provided an oral fluid specimen (N = 1217), 2011.

http://dx.doi.org/10.1371/journal.pone.0090805.t001

HIV testing and undiagnosed Infection

Half of the sample of men who provided an oral fluid specimen (610 of 1202, 50.7%) said that they had undergone an HIV test in the previous 12 months. Of the 59 men who tested positive, 44 (74.6%) reported that their last HIV test result was positive, 14 (23.7%) reported that it was negative, and one did not report his test result (but he perceived himself to be HIV-negative) indicating that 15 men (25.4%) were undiagnosed at the time of the survey. Of these, 13 perceived themselves to be HIV-negative and two reported that they did now know their HIV status; none perceived themselves to be HIV-positive. Furthermore, four reported having tested (HIV-negative) in the previous six months and three reported testing between six to 12 months previously. In comparison, 26 of 44 (59.1%) diagnosed HIV-positive men had tested in the previous six months and a further five (11.4%) had tested between six to twelve months previously.

The testing behaviour of diagnosed and undiagnosed HIV-positive men was examined by comparing their reasons for testing and the locations at which they had tested in the previous 12 months (Table 2). Note the small numbers in each group suggest caution in interpreting these results. Fourteen diagnosed men reporting having an STI other than HIV in the previous 12 months compared with only one undiagnosed man (Table 2). Among men tested for HIV and/or other STIs in the previous 12 months, most reported testing at specialist sexual health, including gay-specific, services (23/36 diagnosed men, 6/8 undiagnosed men and 458/594 HIV-negative men) (data not shown). Venue and home testing were not used by the HIV diagnosed and undiagnosed men but were reported by a small number of HIV-negative men (n = 34). Testing in the primary care setting was reported by 105 (18.1%) HIV-negative men, but only two diagnosed HIV-positive men and two undiagnosed men.

thumbnail
Table 2. HIV infection status and sexual health testing behaviour of MSM who answered the questionnaire and provided an oral fluid specimen (N = 1217), 2011.

http://dx.doi.org/10.1371/journal.pone.0090805.t002

Comparison of HIV prevalence, testing and undiagnosed infection between 2005, 2008 and 2011

The HIV prevalence rate is similar across the three surveys and the proportion of HIV-positive men who were undiagnosed remained unchanged between 2008 and 2011. HIV testing in the previous 12 months increased significantly between 2005 and 2011; half of the sample reported having tested in the previous 12 months in 2011 compared with one third in 2005 (Table 3). However, when directly comparing 2008 and 2011, the increase over the last three years was not significant (AOR = 1.16, 95% CI 0.99–1.37, p = 0.07). We also examined the trend in self-reported sexual risk behaviours between 2005 and 2011 (Table 3). There was a significant increase in UAI with casual partners from 19.8% in 2005 to 25.4% in 2011. There was also a significant change in self-reported STIs over time: following a decrease between 2005 and 2008, the proportion reporting this returned to the 2005 level in 2011 (Table 3). When directly comparing 2008 and 2011 and adjusting for age, qualification level, employment status and frequency of gay scene use, which differed between the surveys, the increase in self-reported STIs between the two years was significant (AOR = 1.49, 95% CI 1.15–1.94, p = 0.003).

thumbnail
Table 3. HIV prevalence, self-reported HIV status, HIV and sexually transmitted infection testing behaviour among MSM providing an oral fluid specimen across the survey years 2005, 2008 and 2011.

http://dx.doi.org/10.1371/journal.pone.0090805.t003

Discussion

HIV testing is considered to be one of the most important measures in reducing HIV transmission among MSM and testing uptake in Scotland increased in the early part of the last decade, largely as a result of the introduction of opt-out testing [2][4]. In 2008, there was a concurrent decrease in undiagnosed HIV amongst our community-based survey participants [9]. However, the data presented here indicate that HIV prevalence has remained stable between 2005 and 2011, the level of undiagnosed HIV infection in MSM in 2011 remains the same as that recorded in 2008 (at one quarter of the positive cohort in this study), and there has been only a marginal further increase in HIV testing. Whilst there is evidence from national surveillance data that indicates new transmissions occurred during this time, national data also indicate little change in the prevalence [3]. In a recently published modelling study using data on MSM in England and Wales over the ten year period 2001 to 2010, there was no decrease in incidence despite an increase in HIV testing rates and high treatment coverage [10]. This study is not designed to measure incidence due to a number of limitations in its design; even a crude measure, using the self-reported HIV testing interval which is not reported by all study participants, estimates a level higher than that described in the Scottish study by McDonald et al which utilised locally collected testing data applicable to this population [6]. Notwithstanding the need for measuring incidence in this population, these results, along with the previous study results, provide valuable insights into the HIV testing and infection status of our MSM population over time. The undiagnosed proportion in our study is similar to the estimate for MSM at the UK level and presents further challenges for the prevention of HIV infection in this group [1], [11]. If the epidemic is being sustained through transmission from the undiagnosed fraction, as is commonly believed, what further actions are required to increase testing and ultimately reduce this?

Just over half of the sample reported having an HIV test in the previous 12 months, regardless of HIV status. Unsurprisingly, HIV testing within the previous six months was highest among men living with diagnosed HIV (reported by 59.1% of men compared with 32.5% or 26.7% of men who were HIV-negative or undiagnosed, respectively) as this likely reflects visits for HIV specialist care where blood samples are taken for viral load measurement in those who knew their HIV diagnoses, or for repeat testing to confirm a recent diagnosis. However, this cannot be established from our data as men were not asked their date of diagnosis or their reason for their most recent HIV test. Among men with undiagnosed HIV, it is interesting to note that their reason for testing was as part of a routine check up or following a risk event. This suggests a willingness to test and a level of awareness that offers the opportunity for targeted HIV prevention including the promotion of frequent HIV testing among those at highest risk.

Our results suggest that more must be done to increase the proportion of ‘at risk’ men testing as frequently and regularly as guidelines recommend. In the UK, the BHIVA/BASHH guideline recommends at least annual testing or more frequently if there is ongoing high risk exposure, or clinical symptoms suggestive of seroconversion in MSM and repeat testing among those who test negative but where an exposure may have occurred during the window period [12]. This is a similar approach recommended for those at risk by the CDC [13], however, these guidelines also recommend an opt-out testing strategy for all patients in all health care settings no matter their presenting condition. This contrasts with the UK policy which recommends expanded testing according to local prevalence. HIV test uptake is good among those attending GUM services where only 9% are known to decline an HIV test [14]. The challenge is how to further improve testing opportunities and to encourage more frequent testing.

While our data indicate that most men in the survey are using conventional HIV testing venues, these may not satisfy the needs of all those at risk of infection who wish a test. In a recent survey to examine barriers to HIV testing, over a ten year period to 2010, among MSM in Glasgow, it was apparent that while HIV testing has been partially normalised during this time, both behavioural (for example, fear of a positive test) and structural barriers (such as clinic opening times and testing waiting times) remained [15]. It is essential that these barriers to testing be addressed if HIV test normalisation is to be fully accepted. One strategy could be to increase opportunities for testing in convenient locations, such as through outreach (including saunas if feasible and acceptable to staff and clients) and community-based clinics using rapid HIV tests. These strategies (notwithstanding some concerns about confidentiality and availability of post-test counselling) have been successful in reducing barriers to testing, targeting populations at risk, diagnosing HIV in those who were unaware of their infection, and were acceptable to clients and staff [16][20]. Furthermore, the use of home testing kits for HIV (which will become legally available in the UK in April 2014) may be explored as a method to increase, and help to normalise, HIV testing.

In the multivariate analysis, the most significant finding was that men with a self-reported STI diagnosis in the past 12 months were twice as likely to be HIV-positive. It is also worthy of note that when comparing diagnosed, undiagnosed and HIV-negative men, it was men living with diagnosed HIV who reported the highest level of STI diagnoses despite similar levels of STI testing among diagnosed and undiagnosed men. It is, however, unknown whether their STI test was prior to, after, or concurrent with the HIV diagnosis and it is not possible to determine with which one or more of the other STIs men were diagnosed. Whilst the likelihood of HIV acquisition (and transmission) is increased in the presence of infection with other major acute STIs, particularly rectal gonorrhoea [21], [22] and levels of STI and HIV co-infection in this population remain a concern [23], [24], an increase in UAI with casual partners was also apparent in 2011; the first such change in sexual risk behaviour evident in almost a decade [25], [26]. In addition, we have recently shown that STI and HIV testing are strongly associated, and as such, sexual health screening presents an opportunity for HIV prevention with HIV-negative and HIV-positive men [27]. STI management, including increasing the frequency of sexual health checkups, possibly via a recall system (similar to that used in screening programmes and other areas of the health service), with rapid treatment, HIV testing for HIV-negative men, and continued HIV prevention and safer sex advice should be an essential component of the HIV prevention toolkit.

There are, however, some limitations to our study. This is a community based sample, which will not be generalisable to all MSM living in Scotland, although it is set in the two largest cities where the majority of new HIV infections are reported. The use of self-completed questionnaires may result in some recall and reporting biases, but the anonymous nature of the survey should attempt to limit these. Note also that the anonymous nature of the survey means that we cannot identify and exclude men who may have completed the questionnaire more than once in any given year; the number is thought to be very small given the short timeframe of data collection and the training of fieldworkers to avoid this. In addition, it is not possible, due to the anonymity inherent to the cross-sectional nature of the study, to identify men who have participated in more than one of the triennial surveys and thus, determine the seroconversion rate. There are a small number of HIV-positive men and of these, a small number who were undiagnosed at the time of the survey, suggesting caution in the interpretation of these results. It should be noted that while there is an association between HIV serostatus and behaviour, this is not causal as one may be a consequence of the other in a bidirectional manner. Notwithstanding these caveats, these results are comparable in response rates and the proportion providing oral fluid specimens to our previous surveys [9], [28]. Although younger men (aged less than 25) and men reporting UAI with casual partners were more likely to provide oral fluid specimens, there were no differences in HIV testing behaviours or in self-reported HIV status.

It is recognised that a combination prevention approach is likely to be the key to reducing the burden of HIV infection among MSM [29], [30]. HIV testing is an important component of this [31] and the stabilisation in rates of HIV testing and undiagnosed infection in our sample between 2008 and 2011 suggest the opt out policy, implemented in the early part of the first decade of this century, may have reached its limit in terms of maximising the uptake of HIV testing as a routine test in this population. Further efforts to improve testing opportunities and encourage more frequent testing are required and should evaluate greater use of community-based and rapid testing initiatives. New biomedical HIV prevention strategies, including treatment as prevention (TasP), present new opportunities but also require frequent and regular testing if they are to be effective [29], [30]. Our results suggest there is indeed more to be done to increase the frequency of HIV testing to the extent required for TasP to be effective in our prevention efforts.

Acknowledgments

The authors wish to gratefully acknowledge and thank the Survey Office at the MRC/CSO Social and Public Health Sciences Unit, the fieldworkers who distributed and collected the survey questionnaires and the oral fluid specimens, the venue owners and staff in the bars and saunas for permitting access to their premises and clients, and the laboratory staff at the West of Scotland Specialist Virology Centre who undertook the HIV testing. Thanks also to all the men who participated in the survey.

We are committed to maximising the use of the Gay Men's Sexual Health Survey data to advance knowledge and improve sexual health. We welcome proposals for collaborative projects and data sharing, which can be submitted via the study website http://gaymensurvey.sphsu.mrc.ac.uk/data-sharing.

Author Contributions

Wrote the paper: JL LW. Devised the paper and wrote the first draft: LW. Cleaned and prepared the data: JL. Conducted the quantitative analyses: JL. Designed the study, supervised, and was the primary investigator of the MRC Gay Men's Sexual Health Survey, Scotland: LM. Contributed to subsequent drafts and approved the final version of the manuscript: LW JL LM.

References

  1. 1. Aghaizu A, Brown AE, Nardone A, Gill ON, Delpech VC, et al.. HIV in the United Kingdom 2013 Report: data to end 2012. November 2013. Public Health England, London. Available: http://www.hpa.org.uk/Publications/InfectiousDiseases/HIVAndSTIs/1311HIVintheUk2013report/ Accessed 2014 Feb 11.
  2. 2. Scottish Government (2005) Respect and Responsibility: Strategy and Action Plan for Improving Sexual Health. Edinburgh: Scottish Government, 2005. Available: http://www.scotland.gov.uk/Publications/2005/01/20603/content. Accessed 2014 Feb 11.
  3. 3. Cullen B, Wallace L, Codere G, Goldberg D (2010) Focus: HIV prevalence among non-injecting drug using heterosexuals, injecting drug users (IDUs), and men who have sex with men (MSM) who undergo attributable HIV testing in Scotland: 2008 update. HPS Weekly Report 44 (8) 72–75.
  4. 4. Sexual Health Epidemiology Group. Scotland's Sexual Health information 2009. Health Protection Scotland and Information Services Division, November 2009.
  5. 5. Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, et al. (2009) Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia. Ann Epidemiol 19 (6) 423–431. doi: 10.1016/j.annepidem.2009.03.004
  6. 6. McDonald SA, Hutchinson SJ, Wallace LA, Cameron SO, Templeton K, et al. (2012) Trends in the incidence of HIV in Scotland, 1988–2009. Sex Transm Infect 88 (3) 194–199. doi: 10.1136/sextrans-2011-050132
  7. 7. Hall HI, Holtgrave DR, Maulsby C (2012) HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS 26 (7) 893–896. doi: 10.1097/qad.0b013e328351f73f
  8. 8. Marks G, Crepaz N, Janssen RS (2006) Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 20 (10) 1447–1450. doi: 10.1097/01.aids.0000233579.79714.8d
  9. 9. McDaid L, Hart G (2011) Increased HIV testing and reduced undiagnosed infection among gay men in Scotland, 2005–2008: support for the opt-out testing policy? Sex Transm Infect 87: 221–224. doi: 10.1136/sti.2010.044560
  10. 10. Birrell PJ, Gill ON, Delpech VC, Brown AE, Desai S, et al. (2013) HIV incidence in men who have sex with men in England and Wales 2001–10: a nationwide population study. Lancet Infect Dis 13 (4) 313–318. doi: 10.1016/s1473-3099(12)70341-9
  11. 11. Presanis AM, Gill ON, Chadborn TR, Hill C, Hope V, et al. (2010) Insights into the rise in HIV infection, 2001–2008: a Bayesian synthesis of prevalence evidence. AIDS 24 (18) 2849–2858. doi: 10.1097/qad.0b013e32834021ed
  12. 12. British HIV Association, British Association for Sexual Health and HIV, British Infection Society (2008) UK National Guidelines for HIV Testing 2008. London, British HIV Association. Available: http://www.bhiva.org/HIVTesting2008.aspx. Accessed 2013 Feb 13.
  13. 13. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, et al. (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbid Mortal Weekly Report 2006 55 (RR14) 1–17.
  14. 14. Health Protection Agency (2011) Sexually transmitted infections in men who have sex with men in the UK: 2011 Report.
  15. 15. Flowers P, Knussen C, Li J, McDaid L (2013) Has HIV testing been normalized? An analysis of changes in barriers to HIV testing among men who have sex with men between 2000 and 2010 in Scotland, UK. HIV Medicine 14 (2) 92–98. doi: 10.1111/j.1468-1293.2012.01041.x
  16. 16. Bilardi JE, Walker S, Read T, Prestage G, Chen MY, et al. (2013) Gay and bisexual men's views on rapid self-testing for HIV. AIDS Behav 17 (6) 2093–2099. doi: 10.1007/s10461-012-0395-7
  17. 17. Prestage G, Brown G, Keen P (2012) Barriers to HIV testing among Australian gay men. Sex Health 9 (5) 453–458. doi: 10.1071/sh12033
  18. 18. Centers for Disease Control and Prevention (CDC) (2007) Rapid HIV testing in outreach and other community settings—United States, 2004–2006. Morb Mortal Wkly Rep 56 (47) 1233–1237.
  19. 19. Platteau T, Wouters K, Apers L, Avonts D, Nostlinger C, et al. (2012) Voluntary outreach counselling and testing for HIV and STIs among men who have sex with men in Antwerp. Acta Clin Belg 67 (3) 172–176.
  20. 20. Thornton AC, Delpech V, Kall MM, Nardone A (2012) HIV testing in community settings in resource-rich countries: a systematic review of the evidence. HIV Medicine 13 (7) 416–428. doi: 10.1111/j.1468-1293.2012.00992.x
  21. 21. Jin F, Prestage GP, Imrie J, Kippax SC, Donovan B, et al. (2010) Anal sexually transmitted infections and risk of HIV infection in homosexual men. J Acquir Immune Defic Syndr 53 (1) 144–149. doi: 10.1097/qai.0b013e3181b48f33
  22. 22. Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD (2010) Rectal gonorrhoea and chlamydia reiinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr 53 (4) 537–543. doi: 10.1097/qai.0b013e3181c3ef29
  23. 23. Wallace LA, Cullen B, Winter A, Goldberg DJ (2012) Syphilis in Scotland 2011: update. HPS Weekly Report 46 (31) 265–268 Available: http://www.documents.hps.scot.nhs.uk/ewr/pdf2012/1231.pdf.
  24. 24. Health Protection Agency (2011) Epidemic of Lymphogranuloma venereum (LGV) in men who have sex with men in UK intensifies. Health Protection Weekly Report 5: 24 Available: http://www.hpa.org.uk/hpr/archives/2011/hpr2411.pdf.
  25. 25. Hart GJ, Williamson LM (2005) Increase in HIV sexual risk behaviour in gay men in Scotland, 1996–2002: prevention failure? Sex Transm Infect 81: 367–372. doi: 10.1136/sti.2004.013995
  26. 26. Knussen C, Flowers P, McDaid LM, Hart GJ (2011) HIV-related sexual risk behaviour between 1996 and 2008, according to age, among men who have sex with men (Scotland). Sex Transm Infect 87: 257–259. doi: 10.1136/sti.2010.045047
  27. 27. McDaid LM, Li J, Knussen C, Flowers P (2013) Sexually transmitted infection testing and self-reported diagnoses among a community sample of men who have sex with men, in Scotland. Sex Transm Infect 89 (3) 223–230. doi: 10.1136/sextrans-2012-050605
  28. 28. Williamson LM, Hart GJ (2007) HIV prevalence and undiagnosed infection among a community sample of gay men in Scotland. J Acquir Immune Defic Syndr 45: 224–230. doi: 10.1097/qai.0b013e318058a01e
  29. 29. Padian NS, Buve A, Balkus J, Serwadda D, Cates W Jr (2008) Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet 372 (9638) 585–599. doi: 10.1016/s0140-6736(08)60885-5
  30. 30. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med 365 (6) 493–505. doi: 10.1056/nejmoa1105243
  31. 31. National Institute for Health and Clinical Excellence: Increasing the uptake of HIV testing among men who have sex with men. (2011) Available: http://guidance.nice.org.uk/PH34. Accessed 2014 Feb 11.